1006-65-1,MFCD00464218
Catalog No.:AA0002D1

1006-65-1 | 3-Phenyl-1,2-oxazole

Pack Size
Purity
Availability
Price(USD)
Quantity
  
250mg
98%
in stock  
$86.00   $60.00
- +
1g
96%
in stock  
$131.00   $92.00
- +
5g
96%
in stock  
$520.00   $364.00
- +
10g
96%
in stock  
$932.00 $653.00
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA0002D1
Chemical Name:
3-Phenyl-1,2-oxazole
CAS Number:
1006-65-1
Molecular Formula:
C9H7NO
Molecular Weight:
145.1580
MDL Number:
MFCD00464218
SMILES:
c1ccc(cc1)c1nocc1
Properties
Computed Properties
 
Complexity:
121  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
11  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
0  
Isotope Atom Count:
0  
Rotatable Bond Count:
1  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
2  

Literature

Title: Synthesis and biological evaluation of isoxazole, oxazole, and oxadiazole containing heteroaryl analogs of biaryl ureas as DGAT1 inhibitors.

Journal: European journal of medicinal chemistry 20120801

Title: Fragment-based discovery of bromodomain inhibitors part 2: optimization of phenylisoxazole sulfonamides.

Journal: Journal of medicinal chemistry 20120126

Title: Phenyl isoxazole voltage-gated sodium channel blockers: structure and activity relationship.

Journal: Bioorganic & medicinal chemistry letters 20110701

Title: Novel mechanism of inhibition of human angiotensin-I-converting enzyme (ACE) by a highly specific phosphinic tripeptide.

Journal: The Biochemical journal 20110515

Title: Use of the nitrile oxide cycloaddition (NOC) reaction for molecular probe generation: a new class of enzyme selective histone deacetylase inhibitors (HDACIs) showing picomolar activity at HDAC6.

Journal: Journal of medicinal chemistry 20080814

Title: Carbonic anhydrase inhibitors: Valdecoxib binds to a different active site region of the human isoform II as compared to the structurally related cyclooxygenase II 'selective' inhibitor celecoxib.

Journal: Bioorganic & medicinal chemistry letters 20060115

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:1006-65-1 Molecular Formula|1006-65-1 MDL|1006-65-1 SMILES|1006-65-1 3-Phenyl-1,2-oxazole
Catalog No.: AA0002D1
1006-65-1,MFCD00464218
1006-65-1 | 3-Phenyl-1,2-oxazole
Pack Size: 250mg
Purity: 98%
in stock
$86.00 $60.00
Pack Size: 1g
Purity: 96%
in stock
$131.00 $92.00
Pack Size: 5g
Purity: 96%
in stock
$520.00 $364.00
Pack Size: 10g
Purity: 96%
in stock
$932.00 $653.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA0002D1
Chemical Name: 3-Phenyl-1,2-oxazole
CAS Number: 1006-65-1
Molecular Formula: C9H7NO
Molecular Weight: 145.1580
MDL Number: MFCD00464218
SMILES: c1ccc(cc1)c1nocc1
Properties
Complexity: 121  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 11  
Hydrogen Bond Acceptor Count: 2  
Hydrogen Bond Donor Count: 0  
Isotope Atom Count: 0  
Rotatable Bond Count: 1  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 2  
Literature fold

Title: Synthesis and biological evaluation of isoxazole, oxazole, and oxadiazole containing heteroaryl analogs of biaryl ureas as DGAT1 inhibitors.

Journal: European journal of medicinal chemistry20120801

Title: Fragment-based discovery of bromodomain inhibitors part 2: optimization of phenylisoxazole sulfonamides.

Journal: Journal of medicinal chemistry20120126

Title: Phenyl isoxazole voltage-gated sodium channel blockers: structure and activity relationship.

Journal: Bioorganic & medicinal chemistry letters20110701

Title: Novel mechanism of inhibition of human angiotensin-I-converting enzyme (ACE) by a highly specific phosphinic tripeptide.

Journal: The Biochemical journal20110515

Title: Use of the nitrile oxide cycloaddition (NOC) reaction for molecular probe generation: a new class of enzyme selective histone deacetylase inhibitors (HDACIs) showing picomolar activity at HDAC6.

Journal: Journal of medicinal chemistry20080814

Title: Carbonic anhydrase inhibitors: Valdecoxib binds to a different active site region of the human isoform II as compared to the structurally related cyclooxygenase II 'selective' inhibitor celecoxib.

Journal: Bioorganic & medicinal chemistry letters20060115

Building Blocks More >
10072-97-6
10072-97-6
Pregn-4-ene-3,20-dione, 9,11-epoxy-17,21-dihydroxy-, (9β,11β)- (9CI)
AA0002N0 | MFCD28358974
1008402-47-8
1008402-47-8
Bis-mal-peg3
AA0002WT | MFCD22683311
100957-76-4
100957-76-4
1-((1H-Indol-3-yl)methyl)piperidine-4-carboxylic acid
AA000380 | MFCD06739714
1010120-55-4
1010120-55-4
5-Bromo-[1,2,4]triazolo[1,5-a]pyridin-2-ylamine
AA0003G9 | MFCD11655928
1011722-07-8
1011722-07-8
2-Cyanopyridine-5-boronic acid
AA0003TB | MFCD10696633
1013405-79-2
1013405-79-2
3-[3-(Benzyloxy)phenyl]phenylacetic acid
AA00046X | MFCD20231507
101490-85-1
101490-85-1
Resorufin beta-d-glucopyranoside
AA0004IP | MFCD00037662
1015845-98-3
1015845-98-3
1-(4-Butylphenyl)-1H-pyrazole-4-carbaldehyde
AA0004TH | MFCD08691650
1016843-83-6
1016843-83-6
Benzenepropanenitrile, 4-methyl-3-nitro-β-oxo-
AA00054R | MFCD09941734
1017793-59-7
1017793-59-7
1,6-Naphthyridine-3-carboxylic acid
AA0005HP | MFCD07366468
Submit
© 2017 AA BLOCKS, INC. All rights reserved.